Lannett Appoints Michael Bogda As President - Quick Facts

(RTTNews) - Lannett Company Inc. (LCI) announced that it has appointment Michael Bogda as president, effective December 1, 2014. Arthur Bedrosian remains the company's chief executive officer.

Most recently, Bogda, 53, served as Teva Pharmaceuticals' executive vice president Americas Technical Operations, overseeing production, sourcing and supply chain, among other responsibilities. Prior to that, he held a number of positions of increasing responsibility for Barr Pharmaceuticals, rising to president and chief operating officer of Barr Laboratories. Previously, Bogda served as vice president operations for Copley Pharmaceuticals.